Novo Nordisk, Actylis ink pact to supply antiseptic in Europe
Actylis, a global manufacturer of raw materials and performance ingredients for the life sciences and specialty chemicals markets, has opened a new 30,000 square foot cGMP facility in Eugene, OR. The multi-million dollar construction commenced in February of 2021 and was completed in September of 2022, with commissioning and qualification completed at the end of January 2023.
The raw materials manufacturer—which debuted last fall after chemical supply veteran Aceto wedded its business with 10 other companies—has kicked off operations at a new “innovative” active pharmaceutical ingredient (API) manufacturing facility in Eugene, Oregon. The 30,000-square-foot plant is equipped to crank out APIs and excipients at both clinical and commercial scales, Actylis said in a release.
After a busy stretch at the bargaining table, chemical supplier Aceto unveiled a new way of working in January, folding a half-dozen acquisitions into its new hybrid production and distribution model. Now, more than two years after starting its manufacturing metamorphosis, Aceto’s efforts have given way to a new company altogether.
Aceto, a supplier for life sciences and advanced technology specialty ingredients, has acquired Biotron Laboratories and Talus Mineral Company (affiliated entities collectively referred to as Biotron herein), leading manufacturers of specialty ingredients for the nutritional supplements industry. The Biotron acquisition expands Aceto’s existing nutraceuticals business and further strengthens its life science sector presence.
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Aceto, the supplier of choice for life sciences and advanced technology specialty ingredients, today announced the acquisition of Biotron Laboratories and Talus Mineral Company (affiliated entities collectively referred to as Biotron herein), leading manufacturers of specialty ingredients for the nutritional supplements industry. The Biotron acquisition expands Aceto’s existing nutraceuticals business and further strengthens its life science sector presence.
The New York-based manufacturer acquired A&C Bio Buffer to help boost its Covid-19 relief efforts and expand its wingspan within manufacturing, the company announced Tuesday.
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)-- Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today the acquisition of Eugene, Oregon-based Cascade Chemistry, manufacturer of active pharmaceutical ingredients (APIs), regulatory starting materials and advanced intermediates. With this acquisition, Aceto now provides customers enhanced support throughout the drug development process and greater access to expanded North American manufacturing, particularly for APIs and advanced intermediates.
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)-- Aceto Corporation, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today the acquisition of a majority stake in Finar Limited. Finar is a leading manufacturer, supplier, and distributor of pharmaceutical excipients, lab chemicals, aquaculture inputs, and food grade additives. The acquisition complements Aceto’s growth strategy, enhancing and expanding the company’s manufacturing footprint, R&D capabilities, and quality expertise.
Sygnature Discovery is investing £3 million in new instrumentation and equipment to strengthen its high-throughput screening (HTS) and translational oncology service offerings. Part of the investment will be used to establish internal flow cytometry support for ex-vivo tumor analysis, the company disclosed in a press release dated Dec. 16. Sygnature had added HTS capabilities to its range of identification solutions in November 2019.